Rights and permissions
About this article
Cite this article
Rituximab added to CHOP worth it among elderly patients with DLBCL. Pharmacoecon. Outcomes News 480, 6 (2005). https://doi.org/10.2165/00151234-200504800-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504800-00014